 | • レポートコード：MRC2203A750 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料では、世界の血管造影装置市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（血管造影システム、消耗品）分析、技術別（MRI、CT、X線、その他）分析、用途別（脳、頸動脈、末梢、大動脈、冠状動脈）分析、エンドユーザー別（病院、診断センター、外来手術センター）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来の傾向などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の血管造影装置市場規模：製品別（血管造影システム、消耗品） ・世界の血管造影装置市場規模：技術別（MRI、CT、X線、その他） ・世界の血管造影装置市場規模：用途別（脳、頸動脈、末梢、大動脈、冠状動脈） ・世界の血管造影装置市場規模：エンドユーザー別（病院、診断センター、外来手術センター） ・世界の血管造影装置市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（AngioDynamics Inc.、Boston Scientific Corporation、Abbott Laboratories、...） ・市場機会・将来の傾向 |
The cardiovascular diseases which include heart attacks, strokes, and other circulatory diseases have become the leading cause of premature deaths. According to the World Health Organization, 2017, cardiovascular diseases account for nearly 17.9 million deaths per year, and this number is expected to grow to more than 23.6 million by 2030. Hence, the increasing number of cardiovascular diseases is driving the demand for angiography devices, which may ultimately result in the growth of the angiography devices market. Furthermore, other factors, such as rapid technological advances, increasing awareness of the population, and a high preference for minimally invasive procedures, are supplementing the market growth.
Key Market Trends
The Hospital Segment is Expected to Dominate the Market During the Forecast Period
The main factors attributing to the dominance of the hospital segment are the availability of the larger patient pool, high resource availability, high penetration in diverse geographical locations, availability of accompanying healthcare infrastructure and procedures, availability of skilled labor, and affordability via government funding. A large number of complex cardiac disease cases are on the rise, with the growth in the number of deaths due to cardiovascular diseases, across both the developed and emerging markets. The high accessibility and affordability of hospitals, as compared to the specialty clinics, attract a large patient population suffering from cardiovascular diseases. The profitability index of hospitals also increases, as they benefit from the bulk purchase discounts and trade agreements with the manufacturers and suppliers. Furthermore, these trade agreements open new avenues to timely upgradation and early access to technologically advanced products by the manufacturers, enhancing the hospital’s treatment capability.
North America Dominates the Angiography Devices Market
North America dominates the angiography devices market, owing to the high adoption rate of minimally invasive procedures, availability of reimbursements, rising geriatric population, and high replacement rates of medical equipment. Factors, such as a good network of medical device companies and a large number of hospitals across cities and states with good funding opportunities, primarily help the region dominate the market. Furthermore, good support from government facilities helps in the development required for the overall treatment of cardiovascular diseases in the healthcare sector of the region.
Europe is the second-largest market after North America. The significant share of the European countries can be attributed to the high prevalence of cardiovascular diseases, high government investments, faster product approval procedures, and rising adoption of angiography devices due to a large number of angiography screening procedures being performed.
Competitive Landscape
The angiography devices market is consolidated and highly competitive. A few global players dominate the market, primarily due to the stringent product approval process, along with the need for significant technological capabilities. The key market players include AngioDynamics Inc., Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., GE Healthcare, Medtronic PLC, Koninklijke Philips NV, Shimadzu Corporation, Siemens Healthineers AG, and Terumo Corporation.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Geriatric Population and Increasing Prevalence of Cardiovascular Diseases
4.2.2 Growing Demand for Interventional Angiography in Minimally Invasive Surgeries
4.3 Market Restraints
4.3.1 High Procedure and Equipment Cost
4.3.2 Risks Associated with Angiography Procedures
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Angiographic Systems
5.1.2 Consumables
5.1.2.1 Catheters
5.1.2.2 Guidewires
5.1.2.3 Contrast Media
5.1.2.4 Incision Closure Devices
5.1.2.5 Accessories
5.2 By Technology
5.2.1 MRI
5.2.2 CT
5.2.3 X-ray
5.2.4 Other Technologies
5.3 By Application
5.3.1 Cerebral
5.3.2 Carotid
5.3.3 Peripheral
5.3.4 Aortic
5.3.5 Coronary
5.3.6 Other Applications
5.4 By End User
5.4.1 Hospitals
5.4.2 Diagnostic Centers
5.4.3 Ambulatory Surgical Centers
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle-East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AngioDynamics Inc.
6.1.2 Boston Scientific Corporation
6.1.3 Abbott Laboratories
6.1.4 Cardinal Health Inc.
6.1.5 GE Healthcare
6.1.6 Medtronic PLC
6.1.7 Koninklijke Philips NV
6.1.8 Shimadzu Corporation
6.1.9 Siemens Healthineers AG
6.1.10 Terumo Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS